Clinical Trial Update: Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated gefitinib (Iressa) in combination with chemoradiation for locally advanced head and neck cancer; the study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Gefitinib (Iressa) (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED